Method for preparing diabetes medicine injection by using mesenchymal stem cells

By preparing a diabetes drug injection containing mesenchymal stem cells and traditional Chinese medicine extracts, the problem of low efficacy of mesenchymal stem cell therapy has been solved, achieving improvement in diabetes and kidney function, and enhancing the patient's immunity.

CN118902990AInactive Publication Date: 2024-11-08BEIJING HENGFENG MINGCHENG BIOTECHNOLOGY CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202410785606.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-18
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current technologies for treating diabetes with mesenchymal stem cells are not very effective, and the shortage of kidney donors limits the promotion of kidney transplantation. Hemodialysis also has a significant impact on patients' quality of life.

Method used

A diabetes drug injection was prepared by combining mesenchymal stem cells with traditional Chinese medicine extracts, and compound vitamins and amino acids were added to treat hyperglycemia and diabetic nephropathy, reduce immune rejection, and improve kidney function.

Benefits of technology

It improves the treatment effect of diabetes, controls blood sugar levels, improves kidney function, enhances patients' immunity, and reduces immune rejection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The invention provides a method for preparing a diabetes medicine injection by using mesenchymal stem cells, and belongs to the technical field of biological medicines. The mesenchymal stem cells can reduce immunological rejection, the mesenchymal stem cells and the traditional Chinese medicine extract are used at the same time to prepare the medicine injection for diabetes, and the medicine injection can be used for treating hyperglycemia and diabetic nephropathy, can effectively control the blood sugar level and can improve kidney functions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine technology, and in particular to a method for preparing a diabetes drug injection using mesenchymal stem cells. Background Art

[0002] Diabetic nephropathy is the most serious complication of diabetes, and about 1 / 3 of diabetic patients will eventually develop diabetic nephropathy. There are many treatments for diabetic nephropathy, including controlling blood sugar, blood pressure, and reducing proteinuria. End-stage patients can undergo renal replacement therapy, including hemodialysis and kidney transplantation. Kidney transplantation is only effective when pancreatic B cell transplantation is performed at the same time, otherwise renal failure will reoccur. Hemodialysis has a great impact on the patient's quality of life, and kidney transplantation is the most effective means of treating end-stage renal disease today. However, the shortage of kidney sources has greatly limited the promotion of kidney transplantation.

[0003] Mesenchymal stem cells (MSCs) are important members of the stem cell family. They are widely used in the treatment of various diseases because of their multidirectional differentiation potential, self-renewal ability, and secretion of multiple factors to participate in the repair and regeneration of damaged tissues and organs. Under specific induction conditions in vivo or in vitro, MSCs can differentiate into various tissue cells such as pancreatic islets, nerves, vascular endothelium, bone, cartilage, muscle, liver, and myocardium. In addition, MSCs have low immunogenicity and unique immunoregulatory effects, can escape immune recognition, and inhibit immune responses, which provides a basis for the use of allogeneic cells. Previous studies have confirmed that MSCs can be induced to differentiate into pancreatic β cells under specific conditions, which brings hope for the treatment of diabetes.

[0004] However, the effect of using mesenchymal stem cells to treat diabetes in the existing technology is not very high. Summary of the invention

[0005] In view of this, the present invention provides a method for preparing a diabetes drug injection using mesenchymal stem cells, using mesenchymal stem cells to reduce immune rejection, and using mesenchymal stem cells and traditional Chinese medicine extracts at the same time to prepare a diabetes drug injection, which can be used to treat hyperglycemia and diabetic nephropathy, can effectively control blood sugar levels, and improve kidney function.

[0006] The method for preparing a diabetes drug injection using mesenchymal stem cells comprises the following steps:

[0007] (1) separating mesenchymal stem cells, adding DMEM / F12 medium, and culturing them in a CO2 incubator. When the confluence of the mesenchymal stem cells is 80% to 85%, digesting and passage using 0.2% trypsin to obtain a fifth-generation mesenchymal stem cell suspension;

[0008] (2) Preparation of Chinese herbal medicine extract: Astragalus, Salvia miltiorrhiza, Ginseng, Pueraria root, Lycium barbarum, Aconite root and White Peony root are mixed, soaked in 4-5 times amount of water for 2-3 hours, boiled for 2-3 hours, filtered, and the residue is added with 3-4 times amount of water for a second extraction, boiled for 1-2 hours, filtered; the two filtrates are combined, filtered with an ultrafiltration membrane, and then concentrated and freeze-dried to obtain the Chinese herbal medicine extract;

[0009] (3) Mixing the Chinese medicine extract of step (2) with the mesenchymal stem cell suspension of step (1), and then adding compound vitamins, compound amino acids, mannitol, and normal saline to obtain a diabetes drug injection.

[0010] Preferably, the mesenchymal stem cells described in step (1) are any one of umbilical cord mesenchymal stem cells, adipose mesenchymal stem cells, and bone marrow mesenchymal stem cells.

[0011] Preferably, the Chinese herbal extract in step (2) comprises the following raw materials in parts by weight:

[0012] 8-12 parts of Astragalus, 3-5 parts of Salvia miltiorrhiza, 7-10 parts of Ginseng, 4-5 parts of Pueraria, 3-5 parts of Lycium barbarum, 7-10 parts of Aconite root, and 5-7 parts of White Peony Root.

[0013] Preferably, the compound vitamin described in step (3) consists of vitamin A, vitamin D and vitamin C in a mass ratio of 1:3:2.

[0014] Preferably, the compound amino acid in step (3) consists of 4-5 parts of glutamine, 4-5 parts of threonine, 2-3 parts of proline and 2-4 parts of leucine.

[0015] Preferably, in the diabetes drug injection of step (3), the content of the Chinese medicine extract is 10-20 mg / ml, and the content of the mesenchymal stem cells is 5×10 5 ~2×10 6 / mL, compound vitamins 0.5-2mg / ml, compound amino acids 0.2-1mg / ml, mannitol 2-5mg / ml, and the balance is normal saline.

[0016] Compared with the prior art, the present invention has the following beneficial effects:

[0017] The present invention provides a method for preparing a diabetes drug injection using mesenchymal stem cells, using mesenchymal stem cells with differentiation ability and potential for treating diabetes to reduce immune rejection. At the same time, traditional Chinese medicine preparations are added to achieve the purpose of drug hypoglycemia, improve blood sugar and kidney status, improve the treatment effect on diabetes, add vitamins and amino acids, improve the immunity of diabetic patients, and improve physical condition. DETAILED DESCRIPTION

[0018] The present invention will be further described below in conjunction with the embodiments.

[0019] Example 1

[0020] A method for preparing a diabetes drug injection using mesenchymal stem cells, comprising the following steps:

[0021] (1) separating bone marrow mesenchymal stem cells, adding DMEM / F12 medium, and culturing them in a CO2 incubator. When the confluence of the mesenchymal stem cells is 80% to 85%, digesting and passage using 0.2% trypsin to obtain a fifth-generation mesenchymal stem cell suspension;

[0022] (2) Preparation of Chinese herbal medicine extract: 12 parts of Astragalus, 1 part of Salvia miltiorrhiza, 8 parts of Ginseng, 5 parts of Pueraria root, 3 parts of Lycium barbarum, 9 parts of Aconite root, and 6 parts of White Peony root were mixed, and 4 times the amount of water was added to soak for 2 hours, decocted for 2 hours, filtered, and the residue was added with 3 times the amount of water for a second extraction, decocted for 1 hour, and filtered; the two filtrates were combined, filtered with an ultrafiltration membrane, and then concentrated and freeze-dried to obtain a Chinese herbal medicine extract; in this embodiment, filtration, ultrafiltration membrane filtration, concentration, and freeze-drying can all be performed by conventional methods in the art;

[0023] (3) According to the content of Chinese medicine extract of 20 mg / ml, compound amino acid of 0.5 mg / ml, the content of mesenchymal stem cells is 10×10 5 The Chinese medicine extract and the mixed cell suspension are mixed with 100 μg / mL of 1 mg / mL of compound vitamins, 3 mg / mL of mannitol, and the remainder is normal saline. The compound vitamins, compound amino acids, mannitol, and normal saline are then added to obtain a diabetes drug injection; wherein the compound vitamins are composed of vitamin A, vitamin D, and vitamin C in a mass ratio of 1:3:2; the compound amino acids are composed of 5 parts of glutamine, 4 parts of threonine, 3 parts of proline, and 3 parts of leucine.

[0024] Comparative Example 1

[0025] A method for preparing a diabetes drug injection, comprising the steps of Example 1, except that no mesenchymal stem cells are added in Comparative Example 1.

[0026] Comparative Example 2

[0027] A method for preparing a diabetes drug injection, comprising the steps of Example 1, except that no Chinese medicine composition is added in Comparative Example 1.

[0028] The following experiments were conducted using the injections of Example 1 and Comparative Examples 1 to 2:

[0029] Establishment of SD rat diabetic model

[0030] Rats weighing 200-220g were fed a high-fat, high-sugar diet for 30-40 days, and then injected with 40mg / kg streptozotocin. The blood glucose concentration of the rat tail was measured with a blood glucose meter, and rats with blood glucose concentrations higher than 16.7mmol / L for two consecutive times were selected as diabetic models.

[0031] 40 diabetic rats were randomly divided into 4 groups, including experimental group 1, comparative group 1-2 and blank control group. 1 mL of injection solution was injected into the tail vein of the animals every day. After 3 weeks of the experiment, the rats were fasted for 6 hours and given 20% glucose 1 ml·100 g by gavage. -1 Body weight, blood sugar average (mmol·L -1 ), the results are shown in Table 1:

[0032] Table 1

[0033]

[0034]

[0035] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing a diabetes drug injection using mesenchymal stem cells, characterized in that: The following steps are involved: (1) separating mesenchymal stem cells, adding DMEM / F12 medium, and culturing them in a CO2 incubator. When the confluence of the mesenchymal stem cells is 80% to 85%, digesting and passage using 0.2% trypsin to obtain a fifth-generation mesenchymal stem cell suspension; (2) Preparation of Chinese herbal medicine extract: Astragalus, Salvia miltiorrhiza, Ginseng, Pueraria root, Lycium barbarum, Aconite root and White Peony root are mixed, soaked in 4-5 times amount of water for 2-3 hours, boiled for 2-3 hours, filtered, and the residue is added with 3-4 times amount of water for a second extraction, boiled for 1-2 hours, filtered; the two filtrates are combined, filtered with an ultrafiltration membrane, and then concentrated and freeze-dried to obtain the Chinese herbal medicine extract; (3) Mixing the Chinese medicine extract of step (2) with the mesenchymal stem cell suspension of step (1), and then adding compound vitamins, compound amino acids, mannitol, and normal saline to obtain a diabetes drug injection.

2. The method for preparing a diabetes drug injection using mesenchymal stem cells according to claim 1, characterized in that: The mesenchymal stem cells described in step (1) are any one of umbilical cord mesenchymal stem cells, adipose mesenchymal stem cells, and bone marrow mesenchymal stem cells.

3. The method for preparing a diabetes drug injection using mesenchymal stem cells according to claim 1, characterized in that: The Chinese herbal extract in step (2) comprises the following raw materials in parts by weight: 8-12 parts of Astragalus, 3-5 parts of Salvia miltiorrhiza, 7-10 parts of Ginseng, 4-5 parts of Pueraria, 3-5 parts of Lycium barbarum, 7-10 parts of Aconite root, and 5-7 parts of White Peony Root.

4. The method for preparing a diabetes drug injection using mesenchymal stem cells according to claim 1, characterized in that: The compound vitamin described in step (3) is composed of vitamin A, vitamin D and vitamin C in a mass ratio of 1:3:

2.

5. The method for preparing a diabetes drug injection using mesenchymal stem cells according to claim 1, characterized in that: The compound amino acid in step (3) is composed of 4-5 parts of glutamine, 4-5 parts of threonine, 2-3 parts of proline and 2-4 parts of leucine.

6. The method for preparing a diabetes drug injection using mesenchymal stem cells according to claim 1, characterized in that: In the diabetes drug injection of step (3), the content of the Chinese medicine extract is 10-20 mg / ml, and the content of the mesenchymal stem cells is 5×10 5 ~2×10 6 / mL, compound vitamins 0.5-2mg / ml, compound amino acids 0.2-1mg / ml, mannitol 2-5mg / ml, and the balance is normal saline.

Citation Information

Patent Citations

  • Mesenchymal stem cell injection, preparation method and application thereof in preparing medicine for treating diabetes

    CN102920735A

  • Umbilical cord mesenchymal stem cells combined with medicine for treating hyperglycemia and diabetic nephropathy

    CN108310015A

  • Mesenchymal stem cell suspension liquid, preparation method and application thereof

    CN108456655A